Загрузка...
The Value of ADAMTS13 in Predicting Clinical Outcomes in Patients With Acute Ischemic Stroke Receiving Thrombolysis
Objective: To determine the association between baseline ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) antigen level and 90-days clinical outcome in patients with acute ischemic stroke (AIS) receiving recombinant tissue plasminogen activator (rt-PA) thr...
Сохранить в:
| Опубликовано в: : | Front Neurol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7412597/ https://ncbi.nlm.nih.gov/pubmed/32849241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00799 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|